1. Home
  2. WAVE vs CTSO Comparison

WAVE vs CTSO Comparison

Compare WAVE & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eco Wave Power Global AB (publ)

WAVE

Eco Wave Power Global AB (publ)

HOLD

Current Price

$6.17

Market Cap

43.3M

Sector

Utilities

ML Signal

HOLD

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.65

Market Cap

45.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WAVE
CTSO
Founded
2011
1997
Country
Israel
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Medical/Dental Instruments
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.3M
45.9M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
WAVE
CTSO
Price
$6.17
$0.65
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$15.00
$5.38
AVG Volume (30 Days)
12.6K
121.2K
Earning Date
11-12-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$168,000.00
$36,979,520.00
Revenue This Year
N/A
$9.51
Revenue Next Year
$400.00
$24.40
P/E Ratio
N/A
N/A
Revenue Growth
N/A
23.89
52 Week Low
$4.41
$0.60
52 Week High
$17.38
$1.61

Technical Indicators

Market Signals
Indicator
WAVE
CTSO
Relative Strength Index (RSI) 36.02 40.85
Support Level $6.39 $0.60
Resistance Level $7.00 $0.76
Average True Range (ATR) 0.28 0.06
MACD -0.05 -0.01
Stochastic Oscillator 16.22 19.04

Price Performance

Historical Comparison
WAVE
CTSO

About WAVE Eco Wave Power Global AB (publ)

Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographical presence in Israel, USA and Mexico.

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

Share on Social Networks: